iopromide has been researched along with Response Evaluation Criteria in Solid Tumors in 2 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Response Evaluation Criteria in Solid Tumors: An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, L | 1 |
Wang, N | 1 |
Mao, J | 1 |
Liu, X | 1 |
Gao, Z | 1 |
Dai, X | 1 |
Feng, B | 1 |
Yip, C | 1 |
Tacelli, N | 1 |
Remy-Jardin, M | 1 |
Scherpereel, A | 1 |
Cortot, A | 1 |
Lafitte, JJ | 1 |
Wallyn, F | 1 |
Remy, J | 1 |
Bassett, P | 1 |
Siddique, M | 1 |
Cook, GJ | 1 |
Landau, DB | 1 |
Goh, V | 1 |
2 other studies available for iopromide and Response Evaluation Criteria in Solid Tumors
Article | Year |
---|---|
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor.
Topics: Ablation Techniques; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Iohexol; | 2018 |
Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Contrast Media; F | 2015 |